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Overall, the benefits of advanced ceramic materials in biomedical applications have been universally appreciated, 
specifically, in terms of their strength, biocompatibility and wear resistance. However, the amount of supporting data is 
not large and the continuous development of new methods is pertinent for better understanding of the microstructure-
properties relationship and, in general, for obtaining new directives for their further improvement. This paper gives an 




Trauma, degeneration and diseases often make surgical 
repair or replacement necessary. When a person has a 
joint pain the main concern is the relief of pain and 
return to a healthy and functional life style. This 
usually requires replacement of skeletal parts that 
include knees, hips, finger joints, elbows, vertebrae, 
teeth, and repair of the mandible. The worldwide 
biomaterials market is valued at close to $24,000M. 
Orthopaedic and dental applications represent 
approximately 55% of the total biomaterials market. 
Orthopaedics products worldwide exceeded $13 billion 
in 2000, an increase of 12 percent over 1999 revenues. 
Expansion in these areas is expected to continue due to 
number of factors, including the ageing population, an 
increasing preference by younger to middle aged 
candidates to undertake surgery, improvements in the 
technology and life style, a better understanding of 
body functionality, improved aesthetics and need for 
better function1. 
 
Biomaterial by definition is "a non-drug substance 
suitable for inclusion in systems which augment or 
replace the function of bodily tissues or organs". From 
early as a century ago artificial materials and devices 
have been developed to a point where they can replace 
various components of the human body. These 
materials are capable of being in contact with bodily 
fluids and tissues for prolonged periods of time, whilst 
eliciting little if any adverse reactions. 2 
 
Some of the earliest biomaterial applications were as 
far back as ancient Phoenicia where loose teeth were 
bound together with gold wires for tying artificial ones 
to neighbouring teeth. In the early 1900’s bone plates 
were successfully implemented to stabilise bone 
fractures and to accelerate their healing. While by the 
time of the 1950's to 60's, blood vessel replacement 
were in clinical trials and artificial heart valves and hip 
joints were in development.  
 
Even in the preliminary stages of this field, surgeons 
and engineers identified materials and design problems 
that resulted in premature loss of implant function 
through mechanical failure, corrosion or inadequate 
biocompatibility of the component. Key factors in a 
biomaterial usage are its biocompatibility, 
biofunctionality, and availability to a lesser extent. 
Ceramics are ideal candidates with respect to all the 
above functions, except for their brittle behaviour.  
 
2. GENERAL CONCEPTS IN BIOCERAMICS 
 
It has been accepted that no foreign material placed 
within a living body is completely compatible. The 
only substances that conform completely are those 
manufactured by the body itself (autogenous) and any 
other substance that is recognized as foreign, initiates 
some type of reaction (host-tissue response). The four 
types of responses, which allow different means of 
achieving attachment of implants to the muscular 
skeletal system, are given in Figure 1. 
 
Figure 1. Classification of bioceramics according to their 
bioactivity; (a) bioinert, alumina dental implant, (b) 
bioactive, hydroxyapatite (Ca10(PO4)2(OH)2)coating on a 
metallic dental implant, (c) surface active, bioglass, (d) 
bioresorbable tri-calcium phosphate implant (Ca3(PO4)2). 
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When a synthetic material is placed within the human 
body, tissue reacts towards the implant in a variety of 
ways depending on the material type. The mechanism 
of tissue interaction (if any) depends on the tissue 
response to the implant surface. In general, there are 
three terms in which a biomaterial may be described in 
or classified into representing the tissues responses. 
These are bioinert, bioresorbable, and bioactive, which 
are well covered in range of excellent review papers.3-5   
 
The term bioinert refers to any material that once 
placed in the human body has minimal interaction with 
its surrounding tissue, examples of these are stainless 
steel, titanium, alumina, partially stabilised zirconia, 
and ultra high molecular weight polyethylene. 
Generally a fibrous capsule might form around bioinert 
implants hence its biofunctionality relies on tissue 
integration through the implant (Figure 1a).  
 
Bioactive refers to a material, which upon being placed 
within the human body interacts with the surrounding 
bone and in some cases, even soft tissue. This occurs 
through a time – dependent kinetic modification of the 
surface, triggered by their implantation within the 
living bone. An ion – exchange reaction between the 
bioactive implant and surrounding body fluids – results 
in the formation of a biologically active carbonate 
apatite (CHAp) layer on the implant that is chemically 
and crystallographically equivalent to the mineral 
phase in bone. Prime examples of these materials are 
synthetic hydroxyapatite 6,7 [Ca10(PO4)6(OH)2], glass-
ceramic A-W 8,9 and bioglass® 10 (Figure 1b and c)). 
 
Bioresorbable refers to a material that upon placement 
within the human body starts to dissolve (resorbed) and 
slowly replaced by advancing tissue (such as bone). 
Common examples of bioresorbable materials are 
tricalcium phosphate [Ca3(PO4)2] and polylactic–
polyglycolic acid copolymers. Calcium oxide, calcium 
carbonate and gypsum are other common materials that 
have been utilised during the last three decades (Figure 
1d)). 
 
3. THE MORE TRADITIONAL BIOCERAMICS 
 
Many of the more “traditional” ceramics have been 
used for bioceramics applications. Alumina and 
zirconia, for example, have been used as inert materials 
for a range of applications from the 1960’s. Their high 
hardness, low friction coefficient and excellent 
corrosion resistance offers a very low wear rate at the 
articulating surfaces in orthopaedic applications. 
Microstructures are controlled to inhibit static fatigue 
and slow crack growth while the ceramic is under load. 
Alumina is currently used for orthopaedic and dental 
implants. It has been utilised in wear bearing 
environments13 such as the total hip arthroplasties 
(THA) as the femoral head generating reductions in 
wear particles from ultra-high molecular weight 
polyethylene (UHMWPE). Other applications for 
alumina encompass porous coatings for femoral stems, 
porous alumina spacers (specifically in revision 
surgery) and in the past as polycrystalline and single 
crystal forms in dental applications as tooth implants. 
3,11-13  
Compared to alumina, PSZ has higher flexural strength, 
fracture toughness and high Weibull modulus (better 
reliability), as well as lower Young's modulus and the 
ability to be polished to a superior surface finish.14, 15 The 
higher fracture toughness is of importance in femoral 
heads due to the tensile stresses induced by the taper fit 
onto the femoral stem.  
 
Partially stabilized zirconia femoral heads make up about 
25% of the total number of operations per year in Europe, 
and 8% of the hip implant procedures in USA. It has 
been reported that over 400,000 zirconia hip joint 
femoral heads have been implanted since 1985 until 
2001. Most of the zirconia femoral heads (tetragonal 
zirconia polycrystal, TZP) consists of 97 mol%ZrO2 and 
3 mol %Y2O3. Although not quite as hard as alumina, 
PSZ still possesses excellent wear resistance and has 
been used for similar orthopaedic applications as 
alumina. Wear rates of UHMWPE against partially 
stabilised zirconia have been found to be low enough 
such that tribological debris would not be a problem in 
clinical applications. 14, 15 
 
The first x-ray diffraction study of bone was 
published16 by De Jong in 1926, in which apatite was 
identified as the only recognizable mineral phase. He 
also reported marked broadening of the diffraction 
lines of bone apatite, which he attributed to small 
crystal size. It was not until the 1970’s that synthetic 
hydroxyapatite [Ca10(PO4)2(OH)2] was accepted as a 
potential biomaterial that forms a strong chemical bond 
with bone in vivo, while remaining stable, under the 
harsh conditions encountered in the physiologic 
environment. 
 
Since discovery of the bioglasses, which bond to living 
tissue (Bioglass®) by Hench and Wilson17, various 
kinds of bioactive glasses and glass-ceramics with 
different functions such as high mechanical strength, 
high machinability and fast setting ability have been 
developed. The glasses that have been investigated for 
implantation are primarily based on silica (SiO2), 
which may contain small amounts of other crystalline 
phases. The most prominent and successful application 
of this is Bioglass® which can be found in detail in 
various comprehensive reviews.5,9,18,19  Bioactive glass 
compositions lie in the system CaO-P2O5-SiO2. The 
first development of such a bioglass began in 1971 
when 45S5 Bioglass® was proposed with a 
composition of 45% SiO2, 24.5% CaO, 24.5% NaO2, 
and 6% P2O5 by weight.10 Hench5, and Vrouwenvelder 
et al. 20, suggested that bioglass® 45S5 has greater 
osteoblastic activity as compared to hydroxyapatite. Li 
et al., 21 prepared glass ceramics with differing degrees 
of crystallinity and found that the amount of glassy 
phase remaining directly influences the formation of an 
apatitic layer, with total inhibition when the glassy 
phase constituted less than about 5 wt.%.  
 
Due to the surface-active response of these types of 
materials, they have been accepted as bioactive (or 
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surface-active) biomaterials and have found 
applications in middle ear, alveolar ridge maintenance 
implants and other non-load bearing conditions.17 
Kokubo et al. in 1982 produced8 a glass-ceramic 
containing oxyfluorapatite Ca10(PO4)6(OH,F2) and 
wollastonite (CaO.SiO2) in a MgO-CaO-SiO2 glassy 
matrix, which was named A-W glass-ceramic. It was 
reported that this glass-ceramic A-W, spontaneously 
bond to living bone without forming the fibrous tissue 
around them. A bioactive and machinable glass 
ceramic named Bioverit® has also been developed, 
which contains apatite and phlogophite 
(Na,K)Mg3(AlSi3O10)(F)2. It is used in clinical 
applications as artificial vertebra. 
 
4. INNOVATIVE CERAMICS 
 
4.1 New Modified Zirconia Implants 
 
Zirconia ceramic implants somehow have had a 
controversial history regarding their phase 
metastability, degradation in water lubricants in 
simulation studies and influence on friction and wear 
phenomena.  
 
There have been some concerns regarding this 
degradation phenomenon associated with the 
tetragonal-to-monoclinic phase transformation under 
the long-term aqueous condition such as in vivo. One 
of the current manufacturers of zirconia femoral heads 
has improved the conventional zirconia, leading to the 
increased strength and the high resistance to the phase 
transformation. In addition, it was reported that in hip 
simulator testing demonstrated that the polyethylene 
wear against the improved zirconia head is lower than 
that against the CoCr head. When articulated with 
highly cross linked poly ethylene, not only zirconia 
heads but also CoCr heads showed very low wear rates. 
However, because zirconia is more scratch-resistant 
than CoCr, it would be more suitable implant for the 
long-term clinical use. 22 
 
Yttrium stabilised tetragonal polycrystalline zirconia 
(Y-TZP) has a fine grain size and offers the best 
mechanical properties. Low temperature degradation of 
TZP is known to occur as a result of the spontaneous 
phase transformation of the tetragonal zirconia to 
monoclinic phase during ageing at 130-300OC possibly 
within water environment. It has been reported that this 
degradation leads to a decrease in strength due to the 
formation of microcracks and accompanying phase 
transformation.  
 
Recently degradation free new zirconia-alumina 
composites have been reported; TZP/alumina 
composite (80% TZP of [90 mol% ZrO2-6 mol%Y2O3-
4 mol%Nb2O5 composition] and 20% Al2O3.12 Another 
potential composite comprised of 70 vol 
%TZP(stabilized with 10mol%CeO2), and 
30vol%Al2O3 and 0.05mol 5TiO2 is currently being 
investigated in Japan.  
 
Implant stability is critical in obtaining good long-term 
success of total joint replacements. Loss of either 
biological or cement fixation can lead to accelerated 
wear, pain, loss of function, or even fracture of the 
implant, each of which could potentially necessitate 
revision surgery. Fixation strength can be improved by 
using macrotextured (porous or textured) surfaces, 
which enhance the potential for mechanical inter-lock 
at the implant-bone interface. 
 
Oxidized zirconium, a material introduced in 2000 for 
orthopaedic bearing applications (Oxinium™, Smith & 
Nephew, Inc., Memphis, TN) and reported to have 
beneficial wear and abrasion resistance 23, 24, cannot be 
easily processed using traditional porous coating 
techniques.  Therefore, an alternative chemical surface 
texturing method was utilized. Chemical texturing 
process has been used clinically on Ti-6Al-4V total hip 
replacement components to create a surface 
morphology suitable for bone in-growth.25 This 
texturing method, known commercially as ChemTex® 
5-5-5 (CYCAM, Inc., Houston, PA), and a newly 
developed chemical texturing process, known 
commercially as Tecotex® I-103 (Tecomet, Woburn, 
MA), were selected to produce macro-textured surfaces 
(Rmax > 0.4 mm) on a zirconium alloy (Zr-2.5Nb).  
These textured surfaces are subsequently oxidized to 
form a hard ceramic layer uniformly about 5 µm thick 
over the entire surface, which consists predominantly 
of monoclinic zirconia (Figure 2).26 
 
4.2 Simulated Body Fluid (SBF) 
 
One of the most promising methods in bioceramics has 
been the introduction of simulated body fluids (SBF) 
by Kokubo and co-workers27, 28. This synthetic body 
fluid is highly supersaturated in calcium and phosphate 
in respect to apatite under even normal conditions.  
Therefore, if a material has a functional group effective 
for the apatite nucleation on its surface, it can form the 
apatite spontaneously. It is widely accepted that the 
essential requirement for an artificial material to bond 
to living bone is the formation of bonelike apatite layer 
on its surface. Formation of the bonelike apatite layer 
on the bioactive materials can be produced in a 
simulated body fluid (SBF) with ion concentrations 
almost equal to those of the human blood plasma.  
Most current bioceramics research utilises this solution 
to measure the bioactivity of an artificial material by 
examining apatite-forming ability on its surface in SBF 
solution. 
 
Hydroxyapatite layers can be easily produced on 
various organic or inorganic substrates in SBF. Kokubo 
et al. in 1989 showed after immersion in SBF, wide 
range of biomaterial surfaces showed very fine 
crystallites of carbonate ion containing apatite.27 
Osteoblasts have been shown to proliferate and 
differentiate on this apatite layer.  
 
TT 
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Figure 2.  Surface texture SEM images of ; (a) ChemTex® textured (CT) surface, (b) Tecotex® textured (TT) surface, 
and (c) porous sintered bead (SB) coating (30x) (after Heuer et al.26). 
 
 
SBF is a metastable solution and if an apatite 
nucleating functional group is present on a substrate 
within the fluid, the apatite spontaneously nucleates. It 
has been reported that this nucleation rate can be 
increased if excessive amounts of Ca2+ ions, PO4H2, 
and Si-OH, Ti-OH, Zr-OH, Ta-OH, Nb-OH or similar 
functional groups are present28. It has been shown that 
highly porous gels of SiO2, TiO2, ZrO2, Nb2O5 and 
Ta2O5 could form apatite layers on their surfaces in 
SBF.  This has been reported to indicate that above 
mentioned functional groups with a specific structure 
are effective for the apatite nucleation in the body 
environment.28 
 
4.3 Coralline Apatites 
 
Coralline apatites can be derived from the sea coral. 
Coral is composed of calcium carbonate in the form of 
aragonite. As coral is a naturally occurring structure 
and has optimal strength and structural characteristics. 
The pore structure of coralline calcium phosphate 
produced by certain species is similar to human 
cancellous bone, making it a suitable material for bone 
graft applications (Figure 3). Coral and converted 
coralline hydroxyapatite have been used as bone grafts 
and orbital implants since the 1980s, as the porous 
nature of the structure allows in-growth of blood 
vessels to supply blood for bone, which eventually 
infiltrates the implant.  
 
Pore interconnection sizes are of utmost importance 
when hard and soft tissue in-growth is involved. Kühne 
et al., showed29 that implants with average pore sizes of 
around 260 µm had the most successful in-growth as 
compared to no implants (simply leaving the segment 
empty). It was further reported that the interaction of 
the primary osteons between the pores via the 
interconnections allows propagation of osteoblasts.  
 
The hydrothermal method was first used in 1974, for 
hydroxyapatite formation directly from corals by Roy 
and Linnehan.30 It was reported that complete 
replacement of aragonite (CaCO3) by phosphatic 
material was achieved less than 533 K and 103 MPa by 
using the hydrothermal process. In 1996, HAp derived 
from Indian coral using hydrothermal process was 
reported.31 However, the resultant material was in the 

















Figure 3. Comparison of the Australian coral (a) in original state and (b) after hydrothermal conversion.33 
 
(a) (c)(b) 
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During the hydrothermal treatment hydroxyapatite 
replaces the aragonite whilst preserving the porous 
structure. The following exchange takes place: 
 
10CaCO3 + 6(NH4)2HPO4 + 2H2O → 
Ca10(PO4)6(OH)2 + 6(NH4)2CO3 + 4H3CO3  (1) 
 
The resulting material is known as coralline 
hydroxyapatite, whether in the porous coralline 
structure or in powdered form.  
 
Aragonite to carbonate hydroxyapatite was achieved by 
using microwave processing technique. Higher extends 
of conversion were reported.32  
 
Hu et al., 33 succeeded to convert Australian coral to 
monophasic hydroxyapatite by using a two-stage 
process where the hydrothermal method was followed 
by a patented hydroxyapatite sol-gel coating process 
based on alkoxide chemistry. They reported 120% 
increase in the biaxial strength of the double-treated 
coral in comparison to only converted one. 
 
4.4 Calcium Phosphate Coatings 
 
Porous hydroxyapatite has been accepted that due to its 
unfavourable mechanical properties it cannot be used 
under load bearing purposes. For this reason 
hydroxyapatite has been used as thin film coatings on 
metallic alloys. Of the metallic alloys investigated 
titanium based alloys have shown to be the material of 
preference for thin film coatings.34 Titanium alloys 
possesses good mechanical strength and fatigue 
resistance under load bearing conditions. They are 
lightweight, with high strength to weight ratios. 
 
Of the coating techniques utilized, thermal spraying 
tends to be the most commonly used and analysed. 
This technique has been faced with challenges of 
producing a controllable resorption response in clinical 
situations. Besides the set backs, thermally sprayed 
coatings are continually being improved by using 
different compositions and post heat treatments which 
converts amorphous phases to crystalline calcium 
phosphates. Other techniques are being investigated. 
Techniques that are capable of producing thin coatings 
include pulsed-laser deposition35 and sputtering36 
which, like thermal spraying involves high - 
temperature processing. Other techniques such as 
electrodeposition 37,38, and sol-gel39 utilise lower 
temperatures and avoid the challenge associated with 
the structural instability of hydroxyapatite at elevated 
temperatures.40  
 
The advantages of sol-gel technique are numerous; it 
results in a stoichiometric, homogeneous and pure 
coating due to mixing on the molecular scale; reduced 
firing temperatures due to small particles sizes with 
high surface areas; it has the ability to produce uniform 
fine-grained structures (Figure 4); the use of different 
chemical routes (alkoxide or aqueous based); and their 
ease of application to complex shapes with a range of 
coating techniques those being dip, spin, and spray 
coating. The lower processing temperature has another 
advantage; it avoids the phase transition (~1156 K) 
observed in titanium based alloys used for biomedical 
devices. 
 
4.5 Synthetic Bone Graft Ceramics  
 
Bone grafting is currently used in orthopaedic and 
maxillofacial surgery for the treatment of bridging 
diaphyseal defects, non-union, filling metaphyseal 
defects and mandibular reconstruction. Autogeneous 
bone graft is osteogenic (which forms bone, due to 
living cells such as osteocytes or osteoblasts), 
osteoconductive (have no capacity to induce or form 
bonebut they provide an inert scaffold which osseous 
tissue can regenerate bone), osteoinductive (stimulate 
cells to undergo phenotypic conversion to 
osteoprogenitor cell types capable of formation of 
bone). There are no substitutes for autogenous bone; 





Figure 4. SEM and AFM images of  sol-gel (alkoxide) derived hydroxyapatite coatings. 
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Allografts have been used as an alternative, but it has 
low or no osteogenicity, increased immunogenicity and 
resorbs more rapidly than autogenous bone. In clinical 
practice, fresh allografts are rarely used because of 
immune response and the risk of transmission of 
disease. The frozen and freeze-dried types are 
osteoconductive but are considered, at best, to be only 
weekly osteoinductive. Freeze drying diminishes the 
structural strength of the allograft and renders it 
unsuitable for use in situations in which structural 
support is required. Allograft bone is a useful material 
in patients who require bone grafting of a non-union 
but have inadequate autograft bone. Bulk allografts can 
be utilised for the treatment of segmental bone 
defects.41 Their use is well documented for 
reconstruction after resection of bone tumours, 
however not common in reconstruction after trauma in 
which bone lengthening and transport are usually 
required. 
 
Demineralised bone matrix (DBM) was first observed 
by Urist in 1965 to induce heterotopic bone.42 The 
active components of DBM are a series of 
glycoproteins, which belong to a group of transforming 
growth factor family (TGF-β). The members of this 
group are responsible for the morphogenic events 
involved in the development of tissue and organs. Urist 
later isolated a protein from the bone matrix, which 
was termed as the bone morphogenic protein (BMP).42 
DBM is commercially available and used in 
management of non-union of fractures. They are not 
suitable where structural support is required. To date, 
the main delay in developing clinical products has been 
the need to find a suitable carrier to deliver the BMP to 
the site at which its action is required. New generation 
ceramic composites/hybrids could fill this gap. 
Experimentally, BMP-2 and OP-1® (BMP-7) have 
been shown to stimulate the formation of new bone in 
diaphysical defects in the rat, rabbit, dog, sheep and 
non-human primates.43 The use of BMP’s with new 
calcium phosphate derivatives or composites could be 
used for bone remodelling where bone regeneration 
and remodelling is needed such as therapeutic 
applications in osteoporosis. 
 
Bovine collagen mixed with hydroxyapatite is 
marketed as a bone-graft substitute, which can be 
combined with bone marrow aspirated from the site of 
the fracture. Although no transmission of disease has 
been recorded, their use will continue to be a source of 
concern. This material is osteogenic, osteoinductive 
and osteoconductive however it lacks the structural 
strength required. 
 
4.6 Titanium Metal Surface Modifications 
 
Ti metal forms a sodium titanate hydrogel layer on its 
surface, when it is soaked in 5M-NaOH solution at 
60ºC for 24 h.  The gel layer is stabilized as an 
essentially amorphous and sodium titanate layer 
without giving significant change in its graded 
structure, when the Ti metal is subsequently heat-
treated at 600ºC for 1 h.  It was reported that these 
treatments with NaOH and subsequent heat treatment 
gave no adverse effect on mechanical properties of the 
Ti metal.44 This kind of bioactive metal is believed to 
be useful as bone substitute even under load bearing 
portions such as artificial total hip and knee joints, 
spinal cages and dental implants.  More than 70 
patients have been reported to receive artificial total 
hip joints of Ti alloy, modified with titanium beads 
subjected to NaOH treatments in Japan.45 
 
4.7 Nanoapatite-Polymer Fibre Composites 
 
Bone is a composite in which nanosized apatite 
particles are deposited on organic collagen fibres.  
Similar composites could be prepared without the aid 
of living cells, if synthetic organic fibres are fabricated 
into a three-dimensional structure modified with 
functional groups effective for the apatite nucleation on 
their surfaces, and then soaked in SBF.  The resultant 
composite is expected to exhibit bioactivity as well as 
analogous mechanical properties to those of the living 
bone. 
 
For example, ethylene-vinyl alcohol copolymer 
(EVOH) fibres constituting two dimensional fabrics 
were modified with a calcium silicate on their surfaces 
by being subjected to silane coupling treatment and 
subsequent soaking in a calcium silicate solution with a 
molar ratio of Si(OC2H5)4/H2O/C2H5OH/Ca(NO3)2 of 
1.0/4.0/4.0/0.014/0.2.  Kokubo et al.45 in their recent 
work demonstrated that nanosized bonelike apatite 
particles deposited uniformly on individual fibres 
constituting a fabric when soaked in SBF for 2 days. In 
another case, the same fibres were modified with an 
anatase-type titania on their surfaces by being 
subjected to silane coupling treatment, soaking in a 
titania solution with a molar ratio of 
Ti(OiC3H7)4/H2O/C2H5OH/HNO3 of 1.0/1.0/9.25/0.1 
and subsequent soaking in 0.1M-HCl solution at 80ºC 
for 8 d.  Nano-sized bonelike apatite particles deposited 
uniformly on individual fibres constituting a two-
dimensional fabric in SBF.45 
 
As these pioneering works shows, if these kind 
techniques could be successfully applied to three-
dimensional fabrics, bioactive materials similar to 
those of the living hard and soft tissues could be 
obtained. 
 
4.8 Bioceramics in In Situ Radiotherapy and 
Hyperthermia 
 
One of the most common approaches in cancer 
treatment is the removal of the diseased parts, however 
unfortunately recovery or return of full function is 
seldom achieved. Noninvasive treatment techniques 
where only the cancer cells are destroyed were 
introduced in mid 80’s. In 1987, microspheres of 
17Y2O3-19Al2O3-64SiO2 (mol%) glass, 20-30 µm in 
diameter were shown to be effective for in situ 
radiotherapy of liver cancer46.  89Yttrium in this glass is 
non-radioactive but can be activated by neutron 
bombardment, to 90Y, which is a β-emitter with half-
MATERIALS FORUM VOL. 27 (2004) 104 - 114 
© Institute of Materials Engineering Australasia Ltd – Materials Forum Volume 27 - Published 2004 110
life of 64.1 h. They are usually injected into diseased 
liver through the hepatic artery, and entrapped in small 
blood vessels, which block the blood supply to the 
cancer and directly irradiate the cancer with β-rays.  
Since the β-ray transmits living tissue only 2.5 mm in 
diameter and the glass microspheres have high 
chemical durability, the surrounding normal tissue is 




Figure 5. SEM image of Y2O3 microspheres for 
radiotherapy applications (after Kokubo et al.45). 
 
 
These glass microspheres are already clinically used in 
Australia, Canada and U.S.A.  The content of Y2O3 in 
the microsphere is, however, limited to only 17 mole%, 
as they are prepared by conventional glass melting 
techniques. Recently, Kokubo et al. successfully 
prepared pure Y2O3 polycrystalline microspheres 20 to 
30 µm in diameter by high-frequency induction 
thermal plasma melting technique47, (Figure 5).  It was 
reported that they observed higher chemical durability 
than the Y2O3-containing glass microspheres.  It was 
further reported that these ceramic microspheres are 
more effective for in situ radiotherapy of cancer. 
 
Oxygen is known to be poorly supplied to cancerous 
cells to produce lactic acid, and hence can be destroyed 
around 43ºC, whereas the normal living cells can be 
kept alive even around 48ºC.  If ferri- or ferromagnetic 
materials are implanted around cancers and placed 
under an alternating magnetic field, it is expected that 
cancer cells locally heated can be destroyed by 
magnetic hysteresis loss of the ferri- or ferromagnetic 
materials. 
 
Kokubo and co-workers prepared a ferrimagnetic 
glass-ceramic containing 36 wt% of magnetite (Fe3O4) 
200 nm in size in a CaO-SiO2 matrix.  It was reported 
that cancerous cells in medullary canal of rabbit tibia 
were completely destroyed when this glass-ceramic is 
inserted into the tibia and placed under an alternating 
magnetic field.48 This kind of invasive treatment, 
however, cannot be applied to humans, since cancer 
cells metastasize.  In the case of humans, ferri- or 
ferromagnetic material must be injected to the cancer 
in a form of microsphere 20 to 30 µm in diameter 
through blood vessels similar to the radioactive 
microspheres. For this purpose, heat-generating 
efficiency of the ferrimagnetic material must be further 
increased.  Recently microspheres of 20 to 30 µm in 
diameter in which magnetite particles 50 nm in size 
deposited on silica microspheres 12 µm in diameter, 
through deposition of β-FeOOH in a solution and its 
subsequent transformation into Fe3O4 at 600ºC under 
CO2-H2 gas atmosphere. It was reported that its heat 
generating efficiency was about four times that of the 
glass-ceramic described above. 
 
Unlike other molecules that are used to encapsulate 
drugs, fullerenes resist breakdown by the body. This 
stability is especially important for holding compounds 
that would cause harm if released in healthy cells, for 
example, radioactive metal atoms. 
 
L. Wilson49 have modified 60-carbon fullerenes, called 
buckyballs, to home in on bone when injected into the 
body. Gonzalez and Wilson designed their compound 
to stick to hydroxyapatite. They also got a surprise 
when characterizing the compound: The molecule has 
one unpaired electron, making it magnetic. This 
property makes the compound a potential contrast 
agent for magnetic resonance imaging (MRI). A 
contrast agent injected into a patient can sharpen an 
MRI picture, revealing otherwise invisible features.  
 
S. R. Wilson50 is working on fitting radioactive metals 
inside thebuckyball, which as they travel through the 
bloodstream, will emit radiation. But since they are 
excreted intact, they will completely remove the 
radiation from the body after the procedure. He is also 
working on fullerenes that will deliver bone-building 
drugs for osteoporosis. Currently, most of those drugs 
are not well absorbed and are toxic. Buckyballs might 
offer a nontoxic molecular ship to deliver the materials 
safely to fragile bones. And on a more distant horizon, 
buckies may someday carry light-activated and/or 
cancer-killing drugs to tumor cells. Smalley would love 
to see this last application happen soon. The discoverer 
of buckyballs has recently suffered a recurrence of 
lymphatic cancer.  
 
Bianco et.al at the CNRS Institute in Strasbourg51, have 
shown that carbon nanotubes are adept at entering the 
nuclei of cells and may one day be used to deliver 
drugs and vaccines. They have modified nanotubes to 
transport small peptide into the nuclei of fibroblast 
calls. This gives hope that the nanotubes may be useful 
for forming the basis of anti-cancer treatments, gene 
therapies and vaccines. 
 
4.8 Bone Cement Composites 
 
During the last 5 years bone cement materials has 
grown in popularity and are a very promising 
osteoconductive substitutes for bone graft. They are 
prepared like acrylic cements and contains range of 
powders such as monocalcium phosphate, tri calcium 
phosphate and calcium carbonate, which is mixed in a 
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solution of sodium phosphate. These cements are 
produced without polymerisation and the reaction is 
nearly non-exothermic. The final compounds are 
reported to have a strength of 10-100 MPa in 
compression while 1-10 MPa, in tension although very 
weak under shear forces. These composites are 
currently used in orthopaedics in the management of 
fractures. It has been suggested that these materials 
could improve the compressive strength of the 
vertebral bodies in osteoporosis. Injection of calcium 
phosphate cement has been shown to be feasible and it 
does improve their compressive strength.52 
 
Preparation of hydroxyapatite/ceramic composites 
through the addition of various ceramic reinforcements 
has been attempted, metal fibres53, Si3N4 or 
hydroxyapatite whiskers54, Al2O3 platelets55 and ZrO2 
particles.56 In many cases, the composites could not be 
successfully prepared and, because of problems related 
to a poor densification the mechanical properties could 
not be improved. 
 
Hydroxyapatite/metal and hydroxyapatite/polymer 
composites are two typical classes of materials, which 
have been examined for improving the toughness 
characteristics of synthetic hydroxyapatite.56-58 In both 
cases, a toughness improvement can be found, due to a 
crack-face bridging mechanism operated upon plastic 
stretching of metallic or polymeric ligaments. Zhang et al. 
57 proposed a toughened composite consisting of calcium 
hydroxyapatite dispersed with silver particles. This 
material was obtained by a conventional sintering method. 
It was reported that the toughness of these composites 
increased up to 2.45 MPa m1/2 upon loading the mixture, 
with (30 vol%) silver. The use of silver is not only for 
taking advantage of the ductility of silver in terms of 
fracture toughness, but also because silver is inert and has 
anti-bacterial properties.58 Attempts to supersede metal 
alloys by carbon-fiber reinforced plastics and by 
various composites to stabilize fractures have met with 
limited success. Although a new titanium metal core-
composite hip implant has been clinically assessed in 
Europe with promising results.44, 59  
 
 
4.10 Biomimetic Hybrid Composites 
 
The conventional way to synthesize an inorganic 
material-based composite is to subject a mixture of the 
constituent phases to heat treatment. This process is 
also common in the biomaterials production arena; 
however, it is conceptually far from the 
biomineralization process, which occurs in nature. The 
natural process produces fine hybrid structures, which 
are hardly reproducible by classic consolidation 
processes. Traditional sintering route is not directly 
applicable to produce ceramic/polymer composites 
because no polymer will stand at the densification 
temperature of any ceramic material. 
Hydroxyapatite/polyethylene composites have been 
obtained by loading the polymeric matrix with the 
inorganic filler. In recent years, several research groups 
have demonstrated the feasibility of in vitro techniques 
for the synthesis of biomimetic material structures. 27, 
56-58, 60-63 
 
The sophistication of the biomimetic route has not been 
paired yet and these techniques, so far, have not proved 
to be fully applicable for clinical applications although 
various companies started to produce a range of 
clinical products. 62 It can be easily predicted that more 
and more dense hybrid materials will be introduced, 
opening a completely new perspectives in biomaterials 
production and application methods.  
 
A new alternative route, -based on an in situ 
polymerization process, carried out into an inorganic 
scaffold (with submicrometer-sized open porosity)-, 
have also been recently proposed. 58 This method is an 
intermediate one between conventional sintering and 
biomineralization in vitro, because it still employs 
sintering for the preparation of the inorganic scaffold, 
but the subsequent hybridisation of the scaffold with 
organic phases is carried out through a chemical route. 
This method enables the synthesis of biomimetic 
(hybrid) inorganic/organic composites, while aiming at 
relatively complex structural designs; it is rather simple 
and easily reproducible process. A schematic of this 
efficient synthesis route is given in Figure 6. 
 
 
Figure 6. Schematic representation of the in situ polymerization synthesis route of new generation hybrid materials. 
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A common characteristic of natural biomaterials such 
as bone, nacre, sea urchin tooth and other tough hybrid 
materials in nature is the strong microscopic interaction 
between the inorganic and the organic phases. This 
characteristic allows the organic phase to act as a 
plastic energy-dissipating network, forming stretching 
(bridging) ligaments across the faces of a propagating 
crack in a nanoscale level. Such complexity has led to 
the common perception that, to mimic natural designs, 
in situ synthesis techniques should be adopted. 
Precipitation of calcium carbonate or hydroxyapatite 
into a polymeric matrix, for example, has been 
proposed as a novel synthetic route to biomimetic 
composites. 61, 64 Despite significant advances in 
understanding biological mineralization and 
developing new fabrication processes, the composites 
to date obtained by these methods are by far in 
embryonic stage for actual applications, due to their 
low structural performance. 
 
The results of fracture tests carried out on two natural 
biomaterials, bovine femur and Japanese nacre 
(Crassostrea Nippona), in comparison with a synthetic 
hydroxyapatite/nylon-6 composite obtained by in situ 
polymerisation of ε-caprolactam infiltrated into a 
porous apatite scaffold showed that the high work of 
fracture achieved  is about two orders of magnitude 
higher than that of monolithic hydroxyapatite, and it is 
due to stretching of protein or polymeric ligaments 
across the crack faces during fracture propagation. 
 
Although the nanoscale modelling of synthetically 
manufactured hybrids and composites is still in infancy, 
mimicking natural microstructures while using strong 
synthetic molecules may lead to a new generation 
biomaterials, whose toughness characteristics will be 
comparable with the materials available in the nature. 
A formidable challenge remains on the optimisation of 
their morphology and bioactivity in these novel hybrid 
composites. 57 
5. FUTURE OF BIOCERAMICS 
As discussed in this chapter, the properties of 
bioceramics are strongly influenced by the raw 
materials selected for preparation, by the method used 
to fabricate, processes used to consolidate and final 
machining processes utilized. All of these factors 
contribute to their final structures and hence to their 
long-term performance as bioceramics. The 
optimization of bioceramics in medical applications 
can be achieved by further studies of the effects of 
processing conditions on their structures and hence on 
their long- term properties.  
 
In particular, the nature and effect of additives, whether 
to improve biological performance or to ease 
processing, on the local and systemic responses needs 
further investigation. Sometimes improvement of one 
property could be detrimental to other properties. 
 
The scope for biomaterials development will include 
the synthesis of novel materials, the modification of 
those currently available, and the exploration of new 
hybrid and composite materials. 
 
In the early 70’s, bioceramics were employed to 
perform singular, biologically inert roles, such as to 
provide parts for bone replacement. The realization that 
cells and tissues in the body perform many other vital 
regulatory and metabolic roles has highlighted the 
limitations of synthetic materials as tissue substitutes. 
Demands of bioceramics have changed from 
maintaining an essentially physical function without 
eliciting a host response, to providing a more integrated 
interaction with the host. This has been accompanied 
by increasing demands from medical devices to 
improve the quality of life, as well as extend its 
duration. Bioceramics potentially can be used as body 
interactive materials, helping the body to heal, or 
promoting regeneration of tissues, thus restoring 
physiological functions. This approach is being 
explored in the development of a new generation of 
bioceramics with a widened range of applications.  
 
Recently the tissue engineering has been directed to 
take advantage of the combined use of living cells and 
tri-dimensional ceramic scaffolds to deliver vital cells 
to the damaged site of the patient. Feasible and 
productive strategies have been aimed at combining a 
relatively traditional approach such as bioceramics 
implants with the acquired knowledge applied to the 
field of cell growth and differentiation of osteogenic 
cells. A stem cell is a cell from the embryo, fetus, or 
adult that has the ability to reproduce for long periods. 
It also can give rise to specialized cells that make up 
the tissues and organs of the body. An adult stem cell is 
an undifferentiated (unspecialized) cell that occurs in a 
differentiated (specialized) tissue, renews itself, and 
becomes specialized to yield all of the specialized cell 
types of the tissue from which it originated. Cultured 
bone marrow cells can be regarded as mesenchymal 
precursor cell population derived from adult cells. 
They can differentiate into different lineages: 
osteoblasts, chondrocytes, adipocytes and myocytes, 
and undergo limited mitotic divisions without 
expressing telomerase activity. When implanted onto 
immunodeficient mice, these cells can combine with 
mineralized tri-dimensional scaffolds to form a highly 
vascularized bone tissue. Cultured-cells/bioceramic 
composites can be used to treat full-thickness gaps of 
bone diaphysis with excellent integration of the 
ceramic scaffold with bone and good functional 
recovery. Excellent innovative work is in progress and 
clinical applications is becoming quite common. 
 
Ultimately, the field of bioceramics is fundamental to 
advances in the performance and function of medical 
devices, and is a critical part of medicine and surgery. 
Bioceramics science is truly interdisciplinary. 
Therefore, the development of improved bioceramics 
can only be the outcome of advances in physical and 
biological sciences, engineering and medicine. The 
correlations between material properties and biological 
performance will be useful in the design of improved 
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bioceramics, particularly to overcome the problems of 
implant rejection and related infection. 
 
The challenge remains to provide safe and efficacious 
bioceramics with the required properties and an 
acceptable biocompatibility level. As the field of 
biomaterials finds increasing applications in cellular 
and tissue engineering, it will continue to be used in 
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